Back to results
US 2021/0228713 A1Published application
Tlr7 peptide conjugates
AssigneeApros Therapeutics, Inc.
InventorTom Yao-Hsiang WU
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a class of pyrimidine derivative peptide conjugates having enhanced immunomodulating properties. More specifically the peptide conjugate contains a TLR7 agonist and enhances the biological effect of the peptide to which it is coupled, increasing immunogenicity, and or lowering the effective dose of the peptide. In some embodiments, the peptide is an antigen, a vaccine, a peptide-based neoantigen vaccine, or an epitope.
Claims27
A peptide conjugate having the structure of Formula I, or a pharmaceutically acceptable salt thereof,
- wherein
- Peptide is a peptide, wherein (C═O) is attached to (i) the N-terminus of the peptide, or (ii) a side chain of the peptide where the functional group of the side chain to which CO═O is attached is NH2;
- R1a is H or C1-C4 alkyl, wherein the alkyl is optionally substituted with one to three substituents selected from the group consisting of —OH, —NH2, —NHAc, —COOH, —SO2CH3, —SCH3, —OCH3,
- and A1;
- X is H or C1-C4 alkyl, wherein the alkyl is optionally substituted with one to three substituents selected from the group consisting of A2, —OH, and —C(CH3)2OH;
- Y is selected from the group consisting of a bond, —CH2—, —CF2,
- —O—, —S—, —SO2—, —NH—, and —CH2CH2—;
- A1 is selected from the group consisting of
- L1 is selected from the group consisting of a bond, —(CH2)n—, —C(O)NH(CH2)n—,
- —[O(CH2CH2)]n—, —[O(C1-C4 alkylene)]-, —[O(CH2CH2)]n—OCH2CH2CF2—, —C(O)NHCH2CH2—[O(CH2CH2)]m—, and —C(O)NHCH2CH2—[O(CH2CH2)]m—OCH2CH2CF2—;
- A2 is selected from the group consisting of
- L2 is selected from the group consisting of a bond, —(CH2)n—, —C(O)NH(CH2)n—,
- —[O(CH2CH2)]n—, —[O(C1-C4 alkylene)]-, —[O(CH2CH2)]m—, and —C(O)NHCH2CH2—[O(CH2CH2)]m—OCH2CH2CF2—;
- m is an integer from zero to four;
- n and p are independently an integer from one to four;
- and
- o is an integer from zero to four.
14 more elements
Dependencies are inferred from the claim text.